Vetter Pharma-Fertigung GmbH & Co. KG

  • Vetter Headquarter in Ravensburg, Germany
About Vetter Pharma-Fertigung GmbH & Co. KG

Vetter is a leading Contract Development and Manufacturing Organization (CDMO) with headquarters in Ravensburg, Germany, and production facilities in Germany, Austria, and the US. As a global player, the pharmaceutical service provider is also present with its own sales locations in the Asia-Pacific markets of Japan, China, South Korea and Singapore. Around the world, small and large renowned pharma and biotech companies rely on the decades of experience, high quality, modern technologies, reliability, and commitment of more than 6,300 employees. In close partnership with its customers, the Vetter team supplies patients all over the world with medicines, many of which are vital. The CDMO provides support from drug product development through clinical and commercial filling to a wide range of assembly and packaging services for vials, syringes, and cartridges. 

  • DE
  • 2015
    On CPHI since
  • 3
  • 5000+
Company types
Contract Service
Primary activities
Contract Manufacturer
Contact info
Meet us at

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024

Pharmapack Europe 2025

Paris Expo, Porte de Versailles - Hall 7.2 | Paris, France
22 Jan 2025 - 23 Jan 2025

Products from Vetter Pharma-Fertigung GmbH & Co. KG (7)

  • Drug Product Development

    Product Drug Product Development

    Our Vetter Development Services help biopharma customers lay a foundation of scalability, quality, and sustainable value for drug product profiles. We support drug developers in navigating key steps, decisions, and transitions in the product development cycle. This includes primary packaging evaluation, pr...
  • Aseptic filling and visual inspection

    Product Aseptic filling and visual inspection

    For over 40 years, our fill and finish services have helped to keep the world supplied with injectable therapies, many of which are lifesaving. Our partnerships with customers start in the first steps of clinical manufacturing through commercial-scale filling and beyond, including management throughout the...
  • Device Assemply and Packaging

    Product Device Assemply and Packaging

    The injectable drug market is rapidly evolving and includes an array of delivery devices from autoinjectors to pens and other intuitive formats. We provide partnership for drug owners driven by the top-quality, complex considerations and flexibility expected. These services include assembly process des...
  • Analytical Services

    Product Analytical Services

    From a drug product’s first raw materials to its release-ready batches, our experts rigorously evaluate and verify a product’s quality at key steps throughout the manufacturing process. Analytical services include material testing to verify product quality from the early stages of development, cGMP-com...
  • Regulatory Support

    Product Regulatory Support

    Our Chemistry, Manufacturing and Controls (CMC) specialists help customers manage the product’s compliance at every step, from clinical development to market authorization. With decades of experience, our experts provide support in navigating regulatory milestones, including site registration, product ...
  • Logistic Service

    Product Logistic Service

    We have established a proven and optimized process along the logistic chain and are dedicated to provide services from API storage to a ready-to-dispatch product. Our long and successful history has enabled us as experts in storing, packaging and worldwide cold chain shipment for injectables. Our compr...
  • Corporate Service Portfolio

    Product Corporate Service Portfolio

    We place heightened focus on your success as your strategic partner.

    We produce aseptically prefilled syringes, cartridges, vials and dual-chamber systems as a globally operating CDMO partner. We are a family-owned, independent company rooted in 70+ years of history. We do not manufactu...

Vetter Pharma-Fertigung GmbH & Co. KG Resources (21)

  • News Vetter Earns Prestigious Honors Across All Core Categories in the 13th Annual CDMO Leadership Awards

    ●        Recognized as a leading partner for all kinds of pharma and biotech

    ●        Award reaffirms mission to provide the highest possible quality and                value for customers and their patients

    ●        2023 sales result showcases the company's continuous sustainable

  • Video About us I Vetter Corporate Image Video

    Our values make us as pharmaceutical service provider, employer, and family business unique. Find out what stands behind the Vetter name.
  • News Vetter becomes a member of the German Association of Research-Based Pharmaceutical Companies (vfa)

    - Association grants Vetter extraordinary membership  

    - vfa recognizes the importance of pharmaceutical service providers in drug development and production  

    - Vetter serves on key vfa committees 
  • Video Vetter Development Service Chicago | US-Based Clinical Manufacturing Site

    Our US-based clinical development site offers comprehensive services and know-how for a wide variety of compounds, including process development, cGMP clinical batches, regulatory support and more. This state-of-the-art facility features 50K square feet of specialized lab space, 2 clean rooms, and the expertise of over 100 clinical development professionals.
  • News Vetter contributes to commercial launches of eight customer products in 2023

    - Vetter successfully brought eight customer drugs to market after supporting them through the development phases 

    - As an established leader in commercial fill and finish, Vetter has evolved as a trusted provider of drug product development services 

    - New molecules candidates brought to Vetter in the clinic receive strategic counsel and experienced support to guide their path to market and beyond 

  • Video Discover Vetter Secondary Packaging & Device Assembly

    We can package a wide variety of drug delivery systems and formats and offer several services such as cartoning (all paper), blistering, labeling, serialization and aggregation , testing. Our dedicated engineering department specializes in developing novel packaging processes for safety device and delivery systems like pens and autoinjectors.
  • News Vetter’s European clinical site receives permanent Manufacturer’s Authorization

    - Successful inspection completed at clinical site 

    - Inspectors were impressed with systems and processes 

    - Austrian site supports manufacturing and quality control of Human Investigational Medicinal Products 
  • Whitepaper e-book I Going to Market in an Autoinjector

    How to prepare for the device assembly & packaging process
  • News Vetter looks ahead to further expansions to meet supply chain demand

    Ongoing investments in the supply chain for complex injectable medications
    - Committed to sustainable growth and long-term planning
    - Dedicated to making investments to support increased customer demand
    - Maintain efficiency and quality in development and manufacturing processes 

  • Whitepaper e-book I Checklist Clinical Manufacturing

    Get your product to the clinic with confidence

    The shift from preclinical to clinical development is a critical step in the development of your drug product.

    During this transition, you not only have to significantly upscale production of your product, but also make many strategic decisions that will lay important groundwork for your regulatory submission, commercial production of your product, and many other key components of your products life-cycle.

    This eBook will help you build a plan that not only streamlines your products path to the clinic but also sets you up for long-term development and market success - starting with a proven 6-step process for filling your critical clinical batch.

  • News Vetter earns Frost & Sullivan Award for the third time

    Identified as best-in-class CDMO in global biopharmaceutical aseptic fill-and-finish services

    - Best practices in operational efficiency and customer processes
    - Unmatched customer service experience
    - Recognition of strong financial performance
  • Brochure Unlock the full potential of your injectable product

    For over four decades, pharma and biotech companies around the world have relied on us to put their parenteral medications on a path to success. We’re proud to help our customers advance their valuable products with innovative services, cutting-edge technology, and flexible, robust, scalable processes that set our partnership apart.
  • Podcast Recap and Forecast 22/23

    Rizwan Chaudhrey chats with experts across the world of Life Science, Pharma and Bio-Pharma on all things related to drug discovery, development, manufacturing, leadership, entrepreneurship and other topics. Now he launched a new series called reflections and forecast 2022/ 2023. 

    In his first episode he chats with Carsten Press, SVP Key Account Management, Supply Chain Management and Marketing, about Vetter Pharma, its key achievements and challenges in 2022 as well as about how the CDMO changed since the pandemic. Furthermore, they talk about predictions for the Life Science/Pharma sector in 2023, market trends and developments and what can be expected from Vetter Pharma in 2023
  • Podcast From a Pharmacy to a 1bn family-owned CDMO

    Peter Soelkner, Managing Director at Vetter, sat down with Raman Sehgal of the “Molecule to Market” podcast to share his personal background, the history of Vetter, and the ambitious goals the company is striving towards today.
  • News Vetter joins United Nations Global Compact Network

    Vetter (Ravensbury, Germany), the aseptic filling and packaging CDMO has signed up to the UN Global Compact Network. 
  • Webinar CMDO Insights Into Launching an Autoinjector

    The rising demand for at-home self-administered therapies has made patient-friendly formats, such as autoinjectors, a necessity for drug manufacturers. However, the intricacies of manufacturing these devices pose significant challenges. This presentation offers valuable insights into planning the device assembly and packaging process, enabling drug owners to navigate this evolving landscape with confidence and efficiency.
  • News CPHI Trend Report - CDMO Opportunities in the Chinese Market

    Opportunities for contract development and manufacturing organisations (CDMOs) in China continue to grow but many questions remain over what the future of the sector will look like in the world's second largest pharmaceutical market.
  • News Vetter aligns development service laboratory portfolio under one roof

    Bundling of competencies optimizes workflow of customer projects.
  • News Vetter works towards a sustainable energy supply

    All German sites of the pharmaceutical service provider will be supplied with green electricity.